$XGN
EXAGEN INC.

2024 Q4 Form 10-Q Financial Statement

#000127473724000092 Filed on November 12, 2024

View on sec.gov

Income Statement

Concept 2024 Q4 2024 Q3
Revenue $12.51M
YoY Change -6.78%
Cost Of Revenue $5.526M
YoY Change -3.22%
Gross Profit $6.981M
YoY Change -9.41%
Gross Profit Margin 55.82%
Selling, General & Admin $10.16M
YoY Change -10.65%
% of Gross Profit 145.58%
Research & Development $1.481M
YoY Change 5.79%
% of Gross Profit 21.21%
Depreciation & Amortization $400.0K
YoY Change -33.33%
% of Gross Profit 5.73%
Operating Expenses $11.64M
YoY Change -8.85%
Operating Profit -$4.663M
YoY Change -8.01%
Interest Expense -$562.0K
YoY Change -200.9%
% of Operating Profit
Other Income/Expense, Net $197.0K
YoY Change -6.64%
Pretax Income -$5.028M
YoY Change -7.15%
Income Tax
% Of Pretax Income
Net Earnings -$5.028M
YoY Change -7.15%
Net Earnings / Revenue -40.2%
Basic Earnings Per Share -$0.28
Diluted Earnings Per Share -$0.28
COMMON SHARES
Basic Shares Outstanding 17.64M shares 17.39M shares
Diluted Shares Outstanding 18.25M shares

Balance Sheet

Concept 2024 Q4 2024 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $22.04M
YoY Change -22.54%
Cash & Equivalents $22.04M
Short-Term Investments
Other Short-Term Assets $2.934M
YoY Change 31.04%
Inventory
Prepaid Expenses
Receivables $9.387M
Other Receivables $0.00
Total Short-Term Assets $35.56M
YoY Change -27.3%
LONG-TERM ASSETS
Property, Plant & Equipment $7.485M
YoY Change -34.24%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $563.0K
YoY Change -11.76%
Total Long-Term Assets $8.048M
YoY Change -33.04%
TOTAL ASSETS
Total Short-Term Assets $35.56M
Total Long-Term Assets $8.048M
Total Assets $43.61M
YoY Change -28.43%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.105M
YoY Change -33.31%
Accrued Expenses $6.177M
YoY Change -12.54%
Deferred Revenue
YoY Change
Short-Term Debt $0.00
YoY Change
Long-Term Debt Due $430.0K
YoY Change 64.75%
Total Short-Term Liabilities $8.777M
YoY Change -13.26%
LONG-TERM LIABILITIES
Long-Term Debt $19.82M
YoY Change 3.28%
Other Long-Term Liabilities $185.0K
YoY Change -61.78%
Total Long-Term Liabilities $20.01M
YoY Change 1.68%
TOTAL LIABILITIES
Total Short-Term Liabilities $8.777M
Total Long-Term Liabilities $20.01M
Total Liabilities $30.74M
YoY Change -8.04%
SHAREHOLDERS EQUITY
Retained Earnings -$290.6M
YoY Change 6.21%
Common Stock $18.00K
YoY Change 5.88%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $12.87M
YoY Change
Total Liabilities & Shareholders Equity $43.61M
YoY Change -28.43%

Cashflow Statement

Concept 2024 Q4 2024 Q3
OPERATING ACTIVITIES
Net Income -$5.028M
YoY Change -7.15%
Depreciation, Depletion And Amortization $400.0K
YoY Change -33.33%
Cash From Operating Activities -$2.176M
YoY Change -25.25%
INVESTING ACTIVITIES
Capital Expenditures $147.0K
YoY Change 7250.0%
Acquisitions
YoY Change
Other Investing Activities $0.00
YoY Change -100.0%
Cash From Investing Activities -$147.0K
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -121.0K
YoY Change 8.04%
NET CHANGE
Cash From Operating Activities -2.176M
Cash From Investing Activities -147.0K
Cash From Financing Activities -121.0K
Net Change In Cash -2.444M
YoY Change -19.15%
FREE CASH FLOW
Cash From Operating Activities -$2.176M
Capital Expenditures $147.0K
Free Cash Flow -$2.323M
YoY Change -20.25%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Entity Central Index Key
EntityCentralIndexKey
0001274737
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Security12b Title
Security12bTitle
Common Stock, par value $0.001 per share
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
dei Entity Ex Transition Period
EntityExTransitionPeriod
false
CY2023Q4 us-gaap Prepaid Expense And Other Assets
PrepaidExpenseAndOtherAssets
4797000 usd
CY2023Q4 us-gaap Assets Current
AssetsCurrent
47841000 usd
CY2024Q3 us-gaap Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
4855000 usd
CY2024Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
2630000 usd
CY2023Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
3286000 usd
CY2023Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
7531000 usd
CY2024Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
1065000 usd
CY2023Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
976000 usd
CY2024Q3 us-gaap Long Term Debt Current
LongTermDebtCurrent
430000 usd
CY2023Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
264000 usd
CY2024Q3 us-gaap Liabilities Current
LiabilitiesCurrent
8777000 usd
CY2024Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2023Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2024Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2024Q3 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2023Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2024Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2024Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000 shares
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000 shares
CY2024Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
17520335 shares
CY2024Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
17520335 shares
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
17045954 shares
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
12868000 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
22694000 usd
us-gaap Costs And Expenses
CostsAndExpenses
56473000 usd
CY2024Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-4663000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-17690000 usd
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
-5028000 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-5415000 usd
us-gaap Net Income Loss
NetIncomeLoss
-11354000 usd
us-gaap Net Income Loss
NetIncomeLoss
-18116000 usd
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.31
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
18127549 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
18127549 shares
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
2854000 usd
dei Amendment Flag
AmendmentFlag
false
CY2024Q3 us-gaap Prepaid Expense And Other Assets
PrepaidExpenseAndOtherAssets
4135000 usd
CY2024Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
185000 usd
CY2023Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
17045954 shares
CY2024Q3 us-gaap Common Stock Value
CommonStockValue
18000 usd
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
17000 usd
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.03
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.03
CY2024Q3 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
72000 usd
us-gaap Net Income Loss
NetIncomeLoss
-18116000 usd
us-gaap Cost Of Goods And Services Sold Depreciation And Amortization
CostOfGoodsAndServicesSoldDepreciationAndAmortization
1661000 usd
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
119000 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
36693000 usd
dei Trading Symbol
TradingSymbol
XGN
dei Document Period End Date
DocumentPeriodEndDate
2024-09-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity Registrant Name
EntityRegistrantName
EXAGEN INC.
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
92081
CY2024Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
17637278 shares
CY2024Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
22035000 usd
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
36493000 usd
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
20-0434866
dei Entity Address State Or Province
EntityAddressStateOrProvince
CA
dei City Area Code
CityAreaCode
760
dei Local Phone Number
LocalPhoneNumber
560-1501
dei Entity Shell Company
EntityShellCompany
false
CY2024Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
563000 usd
dei Entity Address Address Line1
EntityAddressAddressLine1
1261 Liberty Way
dei Entity Address City Or Town
EntityAddressCityOrTown
Vista
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2024Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
9387000 usd
CY2023Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
6551000 usd
CY2023Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
616000 usd
CY2024Q3 us-gaap Assets
Assets
43605000 usd
CY2023Q4 us-gaap Assets
Assets
56944000 usd
CY2024Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
1105000 usd
CY2024Q3 us-gaap Assets Current
AssetsCurrent
35557000 usd
CY2023Q4 us-gaap Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
5201000 usd
CY2023Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
3131000 usd
CY2024Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
1952000 usd
CY2023Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
2760000 usd
CY2023Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
357000 usd
CY2024Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2023Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2024Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-290570000 usd
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-279216000 usd
CY2023Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
5710000 usd
CY2024Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
10163000 usd
CY2024Q3 us-gaap Costs And Expenses
CostsAndExpenses
17170000 usd
CY2023Q3 us-gaap Costs And Expenses
CostsAndExpenses
18485000 usd
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.31
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.63
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
11902000 usd
CY2023Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2023Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
301893000 usd
CY2024Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
43605000 usd
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2024Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
6177000 usd
CY2024Q3 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
19823000 usd
CY2023Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
19231000 usd
CY2024Q3 us-gaap Liabilities
Liabilities
30737000 usd
CY2023Q4 us-gaap Liabilities
Liabilities
34250000 usd
CY2024Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2023Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2024Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2024Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
303420000 usd
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
56944000 usd
CY2024Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
12507000 usd
CY2023Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
13416000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
41986000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
38783000 usd
CY2024Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
5526000 usd
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
17351000 usd
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
17472000 usd
CY2023Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
11375000 usd
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
31169000 usd
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
35212000 usd
CY2024Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1481000 usd
CY2023Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1400000 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
3719000 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
3789000 usd
us-gaap Costs And Expenses
CostsAndExpenses
52239000 usd
CY2023Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-5069000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-10253000 usd
CY2024Q3 us-gaap Interest Expense Nonoperating
InterestExpenseNonoperating
562000 usd
CY2023Q3 us-gaap Interest Expense Nonoperating
InterestExpenseNonoperating
557000 usd
us-gaap Interest Expense Nonoperating
InterestExpenseNonoperating
1671000 usd
us-gaap Interest Expense Nonoperating
InterestExpenseNonoperating
1769000 usd
CY2024Q3 us-gaap Investment Income Interest
InvestmentIncomeInterest
197000 usd
CY2023Q3 us-gaap Investment Income Interest
InvestmentIncomeInterest
211000 usd
us-gaap Investment Income Interest
InvestmentIncomeInterest
570000 usd
us-gaap Investment Income Interest
InvestmentIncomeInterest
1343000 usd
CY2024Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.28
CY2024Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.28
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.63
CY2024Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
18254937 shares
CY2024Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
18254937 shares
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
17692603 shares
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
17692603 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
17626686 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
17626686 shares
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
22694000 usd
CY2024Q1 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
104000 usd
CY2024Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
553000 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-3360000 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
19991000 usd
CY2024Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
560000 usd
CY2024Q2 us-gaap Net Income Loss
NetIncomeLoss
-2966000 usd
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
17585000 usd
CY2024Q3 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
22000 usd
CY2024Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
217000 usd
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
-5028000 usd
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
12868000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
42460000 usd
CY2023Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
27000 usd
CY2023Q1 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
152000 usd
CY2023Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
986000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-7688000 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
35937000 usd
CY2023Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
978000 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-5013000 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
31902000 usd
CY2023Q3 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
127000 usd
CY2023Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
890000 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-5415000 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
27504000 usd
us-gaap Net Income Loss
NetIncomeLoss
-11354000 usd
us-gaap Cost Of Goods And Services Sold Depreciation And Amortization
CostOfGoodsAndServicesSoldDepreciationAndAmortization
1309000 usd
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
112000 usd
us-gaap Paid In Kind Interest
PaidInKindInterest
206000 usd
us-gaap Paid In Kind Interest
PaidInKindInterest
294000 usd
us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
-111000 usd
us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
-209000 usd
exdx Non Cash Lease Expense
NonCashLeaseExpense
656000 usd
exdx Non Cash Lease Expense
NonCashLeaseExpense
717000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
1330000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
2854000 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
2836000 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
10967000 usd
exdx Increase Decrease In Prepaid Expense And Current Other Assets
IncreaseDecreaseInPrepaidExpenseAndCurrentOtherAssets
-662000 usd
exdx Increase Decrease In Prepaid Expense And Current Other Assets
IncreaseDecreaseInPrepaidExpenseAndCurrentOtherAssets
-727000 usd
us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
-50000 usd
us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
120000 usd
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-720000 usd
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-767000 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-2028000 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-1422000 usd
us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
-1140000 usd
us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
2000000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-13642000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-22811000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
369000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
722000 usd
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
0 usd
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
2000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-369000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-720000 usd
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
22000 usd
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
27000 usd
us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
176000 usd
us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
279000 usd
us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
379000 usd
us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
541000 usd
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
266000 usd
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
177000 usd
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
0 usd
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
10000000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-447000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-10412000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-14458000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-33943000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
62591000 usd
CY2024Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
22235000 usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
28648000 usd
us-gaap Interest Paid Net
InterestPaidNet
1307000 usd
us-gaap Interest Paid Net
InterestPaidNet
1336000 usd
exdx Equipment Purchased Under Notes Payable Obligations
EquipmentPurchasedUnderNotesPayableObligations
706000 usd
exdx Equipment Purchased Under Notes Payable Obligations
EquipmentPurchasedUnderNotesPayableObligations
250000 usd
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
20000 usd
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
81000 usd
CY2024Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
22000000.0 usd
CY2024Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-290600000 usd
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Concentration of Credit Risk and Other Risk and Uncertainties</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financial instruments that potentially subject the Company to credit risk consist principally of cash, cash equivalents and accounts receivable. Substantially all the Company's cash and cash equivalents are held at one financial institution that management believes is of high credit quality. Such deposits may, at times, exceed federally insured limits. The Company has not experienced any losses on its cash or cash equivalents.</span></div>
CY2024Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
12507000 usd
CY2023Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
13416000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
41986000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
38783000 usd
CY2024Q3 us-gaap Restricted Cash
RestrictedCash
200000 usd
CY2024Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
22035000 usd
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
36493000 usd
CY2024Q3 us-gaap Restricted Cash
RestrictedCash
200000 usd
CY2023Q4 us-gaap Restricted Cash
RestrictedCash
200000 usd
CY2024Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
22235000 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
36693000 usd
CY2024Q3 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
600000 usd
CY2023Q3 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
2500000 usd
us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
6200000 usd
us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
2600000 usd
CY2024Q3 us-gaap Financing Receivable Allowance For Credit Loss Excluding Accrued Interest
FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest
0 usd
CY2023Q3 us-gaap Financing Receivable Allowance For Credit Loss Excluding Accrued Interest
FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest
0 usd
CY2024Q3 us-gaap Advertising Expense
AdvertisingExpense
400000 usd
CY2023Q3 us-gaap Advertising Expense
AdvertisingExpense
500000 usd
us-gaap Advertising Expense
AdvertisingExpense
1000000.0 usd
us-gaap Advertising Expense
AdvertisingExpense
1200000 usd
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
2724519 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
2994617 shares
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1 segment
CY2024Q3 us-gaap Other Assets Current
OtherAssetsCurrent
2934000 usd
CY2023Q4 us-gaap Other Assets Current
OtherAssetsCurrent
2871000 usd
CY2024Q3 us-gaap Prepaid Royalties
PrepaidRoyalties
32000 usd
CY2023Q4 us-gaap Prepaid Royalties
PrepaidRoyalties
35000 usd
CY2024Q3 exdx Prepaid Maintenance And Insurance Contracts
PrepaidMaintenanceAndInsuranceContracts
1169000 usd
CY2023Q4 exdx Prepaid Maintenance And Insurance Contracts
PrepaidMaintenanceAndInsuranceContracts
1860000 usd
CY2024Q3 us-gaap Other Prepaid Expense Current
OtherPrepaidExpenseCurrent
0 usd
CY2023Q4 us-gaap Other Prepaid Expense Current
OtherPrepaidExpenseCurrent
31000 usd
CY2024Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
4135000 usd
CY2023Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
4797000 usd
CY2024Q3 us-gaap Property Plant And Equipment And Finance Lease Right Of Use Asset Before Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization
10454000 usd
CY2023Q4 us-gaap Property Plant And Equipment And Finance Lease Right Of Use Asset Before Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization
10970000 usd
CY2024Q3 us-gaap Property Plant And Equipment And Finance Lease Right Of Use Asset Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization
5599000 usd
CY2023Q4 us-gaap Property Plant And Equipment And Finance Lease Right Of Use Asset Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization
5769000 usd
CY2024Q3 us-gaap Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
4855000 usd
CY2023Q4 us-gaap Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
5201000 usd
CY2024Q3 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
400000 usd
CY2023Q3 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
600000 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
1300000 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
1700000 usd
CY2024Q3 us-gaap Accrued Salaries Current
AccruedSalariesCurrent
4413000 usd
CY2023Q4 us-gaap Accrued Salaries Current
AccruedSalariesCurrent
4738000 usd
CY2024Q3 exdx Accrued Purchase Goods And Services Current
AccruedPurchaseGoodsAndServicesCurrent
547000 usd
CY2023Q4 exdx Accrued Purchase Goods And Services Current
AccruedPurchaseGoodsAndServicesCurrent
720000 usd
CY2024Q3 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
283000 usd
CY2023Q4 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
490000 usd
CY2024Q3 us-gaap Customer Refund Liability Current
CustomerRefundLiabilityCurrent
266000 usd
CY2023Q4 us-gaap Customer Refund Liability Current
CustomerRefundLiabilityCurrent
302000 usd
CY2024Q3 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
668000 usd
CY2023Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
1281000 usd
CY2024Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
6177000 usd
CY2023Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
7531000 usd
CY2024Q3 us-gaap Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year
LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear
517000 usd
CY2024Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Next Twelve Months
LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
2097000 usd
CY2024Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
21400000 usd
CY2024Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Three
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
215000 usd
CY2024Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Four
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour
67000 usd
CY2024Q3 exdx Long Term Debt Including Undiscounted Interest
LongTermDebtIncludingUndiscountedInterest
24296000 usd
CY2024Q3 us-gaap Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net
DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet
80000 usd
CY2024Q3 exdx Long Term Debt Undiscounted Interest Amount
LongTermDebtUndiscountedInterestAmount
3963000 usd
CY2024Q3 us-gaap Long Term Debt
LongTermDebt
20253000 usd
CY2024Q3 us-gaap Long Term Debt Current
LongTermDebtCurrent
430000 usd
CY2024Q3 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
19823000 usd
CY2024Q3 us-gaap Purchase Obligation Future Minimum Payments Remainder Of Fiscal Year
PurchaseObligationFutureMinimumPaymentsRemainderOfFiscalYear
8400000 usd
CY2024Q3 us-gaap Purchase Obligation Due In Next Twelve Months
PurchaseObligationDueInNextTwelveMonths
10400000 usd
CY2024Q3 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
1130281 shares
exdx Stock Issued During Period Shares Warrants Exercised Net
StockIssuedDuringPeriodSharesWarrantsExercisedNet
0 shares
CY2024Q3 exdx Stock Issued During Period Shares Warrants Exercised Net
StockIssuedDuringPeriodSharesWarrantsExercisedNet
0 shares
CY2024Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
300000 usd
CY2023Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
200000 usd
CY2024Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
217000 usd
CY2023Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
890000 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1330000 usd
CY2024Q3 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2024Q3 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2024Q3 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
CY2024Q3 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false

Files In Submission

Name View Source Status
0001274737-24-000092-index-headers.html Edgar Link pending
0001274737-24-000092-index.html Edgar Link pending
0001274737-24-000092.txt Edgar Link pending
0001274737-24-000092-xbrl.zip Edgar Link pending
exdx-20240930.htm Edgar Link pending
exdx-20240930.xsd Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
exdx-20240930_def.xml Edgar Link unprocessable
exdx-20240930_lab.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
xgn311-093024.htm Edgar Link pending
xgn312-093024.htm Edgar Link pending
xgn321-093024.htm Edgar Link pending
exdx-20240930_cal.xml Edgar Link unprocessable
exdx-20240930_htm.xml Edgar Link completed
exdx-20240930_pre.xml Edgar Link unprocessable